Trial intelligence / Profile preview

Ketamine versus propofol sedation for colonoscopy

IRCT20220706055402N3Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, triple-blind trial of ketamine and propofol in None (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: Sedation and Pain. Started Feb 2023; status: completed.

02

Drugs

ketaminepropofol

Beyond the preview

Go deeper on IRCT20220706055402N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220706055402N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call